Home » Topics » Regulatory

Regulatory
RSS

New doses of Kadian approved in U.S.

March 15, 2001

Roche seeks FDA approval for Xeloda/Taxotere combination for the treatment of breast cancer

March 9, 2001

FDA approves multidose formulation of Serono's Gonal-F for ovarian stimulation

March 7, 2001

Faulding to market and sell NaPro's paclitaxel in Europe

March 5, 2001

CPMP issues positive opinion for new NeoRecormon indication

March 5, 2001

Early March launch for new antiallergic agent from Kyowa Hakko

Feb. 27, 2001

Iomed enrolls over 300 patients in phase III study for epicondylitis

Feb. 26, 2001

Janssen completes phase III trials of sustained-release formulation of Risperdal

Feb. 26, 2001

Vita-Invest's combination therapy for hypertension completes phase III

Feb. 23, 2001

Therapeutic agents for drug addiction, withdrawal, etc., claimed by Knoll

Feb. 22, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...